- 66
- 162 814
Bachem
Switzerland
Приєднався 17 гру 2014
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
We stand for long-term partnerships and excellent service. Innovation and technological leadership are as important to us as quality and operational excellence. Our passionate and dedicated employees, along with our unique corporate culture are the foundation of our success.
We stand for long-term partnerships and excellent service. Innovation and technological leadership are as important to us as quality and operational excellence. Our passionate and dedicated employees, along with our unique corporate culture are the foundation of our success.
A big thank you from the leadership team
As the year draws to a close, Bachem’s leadership took a moment to say thank you to all employees for their dedication and commitment throughout 2023 in a short video message.
The team spirit and commitment of 2,000 employees is what makes Bachem a truly special company. We wish all our employees and their families a wonderful holiday season and a good start into 2024.
---------------------------------------------------------------------------------------------------------------------------
About Bachem:
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Featuring
Thomas Meier, Chief Executive Officer (CEO)
Alain Schaffter, Chief Financial Officer (CFO)
Günther Loidl, Chief Technology Officer (CTO)
Torsten Wöhr, Chief Marketing Officer (CCO)
Viviane Minder (CHRO)
Achim Plückebaum (CIO)
Learn more about Bachem: www.bachem.com/
The team spirit and commitment of 2,000 employees is what makes Bachem a truly special company. We wish all our employees and their families a wonderful holiday season and a good start into 2024.
---------------------------------------------------------------------------------------------------------------------------
About Bachem:
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Featuring
Thomas Meier, Chief Executive Officer (CEO)
Alain Schaffter, Chief Financial Officer (CFO)
Günther Loidl, Chief Technology Officer (CTO)
Torsten Wöhr, Chief Marketing Officer (CCO)
Viviane Minder (CHRO)
Achim Plückebaum (CIO)
Learn more about Bachem: www.bachem.com/
Переглядів: 1 540
Відео
Health, Safety, Environment (HSE) at Bachem - by Sandra Thöni
Переглядів 567Рік тому
At Bachem, our responsibility towards our employees, the environment, and society is a key element of our corporate strategy. We are proud to contribute to the healthy lives and well-being of all people everywhere as a leading manufacturer of peptides and oligonucleotides for the research, development, and production of pharmaceuticals and as an employer of more than 1100 people on our site. We...
Innovation for peptide and oligonucleotide manufacturing - a few examples
Переглядів 729Рік тому
As the leading CDMO for peptides and oligonucleotides for large molecule manufacturing, it is essential to keep technical leadership and set high industry standards. At Bachem, we are encouraged to be creative, innovative, and able to adapt. We develop and implement unique technical and engineering solutions throughout our production chain. This brief introduction to some of the innovative tech...
Corporate Social Responsibility at Bachem - by Franz Saladin
Переглядів 141Рік тому
Bachem defined sustainability as one of its five strategic foundations. Holding the position as the world-leading specialist in peptides and oligonucleotides does not go without taking responsibility for our employees, society, and the environment. Through our Corporate Social Responsibility Management System, we have identified twenty issues where Bachem substantially impacts the environment a...
Peptide-based In Vitro Diagnostics
Переглядів 310Рік тому
The search for faster and more accurate diagnostic tools has brought strong interest to peptide-based in vitro diagnostics. Synthetic peptides offer high-purity profiles versus biologically produced molecules and can be made with stability or sensitivity-increasing modifications. At Bachem, we have the expertise and state-of-the-art equipment to produce your peptides with a wide range of modifi...
Generic Active Pharmaceutical Ingredients - Liraglutide and other GLP-1 analogues
Переглядів 1,2 тис.Рік тому
Bachem is continuously innovating in the manufacture of synthetic peptides. The synthetic Active Pharmaceutical Ingredient (API) liraglutide is a remarkable example of Bachem's technical and analytical capabilities that help provide patients with safe and affordable generic medicines. In addition to liraglutide, we offer a portfolio of GLP-1 analogues. We are increasing process efficiencies and...
Meet Gilles Parmentier- Head of Global Research Chemicals & Specialties
Переглядів 435Рік тому
Bachem is clearly an innovative company. This is why Gilles Parmentier first joined 20 years ago, and this is why he returned. His team finds innovative ways to face the technological challenges of oligonucleotide chemistry and green chemistry projects for the cosmetics and pharmaceutical industries. The markets Bachem serves are diverse, ranging from all the players in peptide synthesis who ar...
2022 Annual Results - A word with… Thomas Meier, CEO of Bachem
Переглядів 967Рік тому
• Group sales rise to 531.7 million by 5.7% against previous year. • EBITDA at CHF 160.5 million ( 2.0%) with a margin of 30.2%. • Operating income EBIT at CHF 127.2 million (-1.3%) with a margin of 23.9%. • Total investments of CHF 142.6 million and creation of 141 new positions. • Board of Directors proposes an increase of the dividend by CHF 0.05 to CHF 0.75 per share. Outlook: • Bachem expe...
Bachem Oligonucleotide facility tour - Trailer
Переглядів 2,8 тис.Рік тому
This tour is an exclusive walkthrough of Bachem’s oligonucleotide facilities in the company’s Headquarters, Bubendorf, Basel, Switzerland. The oligonucleotide organization consists of two sub-units. First, Oligo Manufacturing with three departments for pilot scale, large scale, and the very large line in the new building. Second, Oligo R&D with two departments for process R&D and CMC developmen...
Semaglutide! What is it, and how does it work?
Переглядів 11 тис.Рік тому
Leading by Experience! As a manufacturer of Semaglutide for future generic and innovative formulations, we have all the answers. It is currently used as an active pharmaceutical ingredient in prescription medicines for the treatment of type II diabetes and Obesity. From a chemical point of view, Semaglutide is a peptide, which means it is a chain of amino acids. Semaglutide can regulate our blo...
Peptides - CMC development for NCE projects quickly explained
Переглядів 3,3 тис.Рік тому
What does a successful drug development process entail? Several critical phases must be completed to obtain market approval for a new drug and its commercial production. The active pharmaceutical ingredient and its formulated form must pass the preclinical and clinical phases I to III. After that, the New Drug Application must be filled, and then the API can be supplied commercially upon market...
Corporate Executive Committee looks back at 2022
Переглядів 5402 роки тому
Our Corporate Executive Committee (CEC) took a look back at the year and expressed gratitude to Bachem employees for their commitment. See what they had to say by watching the video. About Bachem: Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provi...
Regulatory Affairs Services - Partnering for Success
Переглядів 3402 роки тому
Explore how you can benefit from a comprehensive service portfolio when you partner with Bachem Americas Regulatory Affairs (RA). By paving the way through all critical milestones, our regulatory team is committed to achieving a successful outcome for you. From early development to submission and beyond, we can help you along the way. Some of the services we offer include: -Chemistry, Manufactu...
Lyophilization of Peptides and Oligonucleotides
Переглядів 5 тис.2 роки тому
An innovation by Bachem for the downstream process: The patented Lyo-Trays! These trays can be used to measure critical process parameters, such as temperature during lyophilization. They are adaptable to GMP requirements and suitable for handling large volumes of active pharmaceutical ingredients (APIs). Bachem’s Lyo-trays feature several innovations that improve both safety and capacity. Clos...
Bachem in Generics - Leading by Experience
Переглядів 4532 роки тому
At Bachem, we know it's not just our high-quality APIs that help you to make those life-changing masterpieces. It's the whole service and support we give you - based on over 50 years' experience. It's why we constantly seek new ways to create even more cost-effective and sustainable solutions for our customers - at every step of the process. Leading by experience. About Bachem: Bachem is a lead...
Smart Factory at Bachem: Automating and Digitalizing SPPS
Переглядів 9382 роки тому
Smart Factory at Bachem: Automating and Digitalizing SPPS
Continuous chromatography | sustainable optimization of yield & quality
Переглядів 2,6 тис.2 роки тому
Continuous chromatography | sustainable optimization of yield & quality
The successful journey of large scale oligonucleotide manufacturing
Переглядів 2,4 тис.2 роки тому
The successful journey of large scale oligonucleotide manufacturing
Sustainable Propofol manufacturing in Switzerland
Переглядів 1,8 тис.2 роки тому
Sustainable Propofol manufacturing in Switzerland
Risk assessment for a nitrosamine contamination of peptide APIs manufactured by SPPS
Переглядів 3742 роки тому
Risk assessment for a nitrosamine contamination of peptide APIs manufactured by SPPS
AMW | Customer testimonial | Why choose Bachem?
Переглядів 12 тис.2 роки тому
AMW | Customer testimonial | Why choose Bachem?
Oligonucleotides at Bachem - Innovation that transforms lives
Переглядів 16 тис.2 роки тому
Oligonucleotides at Bachem - Innovation that transforms lives
Novel and best approaches in MS characterization of highly modified synthetic RNA?
Переглядів 2702 роки тому
Novel and best approaches in MS characterization of highly modified synthetic RNA?
Industry 4.0 for manufacturing of oligos and peptides
Переглядів 1,3 тис.2 роки тому
Industry 4.0 for manufacturing of oligos and peptides
CMC development of peptides - A case study
Переглядів 4392 роки тому
CMC development of peptides - A case study
Bachem Corporate Management - Do They Still Recall Their First Day?
Переглядів 6962 роки тому
Bachem Corporate Management - Do They Still Recall Their First Day?
2021 Full Year Results - Leadership’s perspectives & highlights
Переглядів 7532 роки тому
2021 Full Year Results - Leadership’s perspectives & highlights
Oligonucleotides - Innovation that transforms lives
Переглядів 1,6 тис.2 роки тому
Oligonucleotides - Innovation that transforms lives
Do it Right, by not Doing it Yourself - the Value of a Good CDMO Partner
Переглядів 5793 роки тому
Do it Right, by not Doing it Yourself - the Value of a Good CDMO Partner
Sehr gute Technologie❤
penis
good
Can you talk any slower
I came here from South Park obesity episode.😂
From india
TLDR: Semaglutide, a synthetic peptide, is a promising treatment for Diabetes type II and Obesity due to its ability to regulate blood sugar and appetite, and can be administered as a tablet instead of injection. 00:00 💡 Semaglutide is a peptide used in prescription medicines for Diabetes type II and Obesity, and medical specialists are excited about it. 00:36 🔍 Semaglutide is a peptide that mimics the function of a hormone in the body, stimulating insulin secretion, inhibiting glucagon, impacting appetite, and slowing down digestion. 01:15 📌 Semaglutide regulates blood sugar and appetite, reducing long-term damage in Diabetes type II and obese patients, and can be administered as a tablet instead of injection. 01:59 💉 Semaglutide is a synthetic peptide manufactured in Switzerland with high purity levels, used to help fight against Diabetes type II and Obesity.
Does this guidance apply to 505b2 submission?
Thanks for the info! Also, The music track is very distracting and makes it difficult to understand.
Bravo! I’m waiting for my treatment.
i need petides but can you make them safe?
interesting
I still don’t know what peptides are
its like code injection
last
no
Yes
fourth (lol)
Nuhuh
𝓅𝓇o𝓂o𝓈𝓂
Perfect ! Congrats to a great team !
Thank you very much!
THIRD
Hamko vatahari vati lena hai
Nice cop
Interesting Powerpoint gerat work!
Interesting!
Masterpice video
SECOND
ｐｒｏｍｏｓｍ
FIRST
Good Video
Thanks!
Did you know there are over 500 known amino acids? Science never fails to amaze!
Great Video! Seeing success always makes me happy. Looking forward to my interview at Bachem AG😁
Congratulations Bachem 👏🏼
Thank you 🙌
Schöner Vortrag, Julius!
Great presentation. Thank you Franz
Glad you enjoyed it!